Trial
NCT02478229
Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
—
Condition
Hepatitis C Viral Infection
Intervention
Sofosbuvir (SOF) and Ledipasvir (LDV)
Why stopped
difficulty recruiting patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-08